Cargando…
Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
Cognitive impairment is closely related to real-life functioning in patients with schizophrenia. The aim of the present study was to evaluate the effects of adjunctive treatment with donepezil on cognition in patients with chronic schizophrenia. This was a 12-week, double-blind, randomized, placebo-...
Autores principales: | Zhu, Weiwei, Zhang, Zhanchou, Qi, Jingfeng, Liu, Fang, Chen, Jindong, Zhao, Jingping, Guo, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106965/ https://www.ncbi.nlm.nih.gov/pubmed/25075190 http://dx.doi.org/10.2147/NDT.S64189 |
Ejemplares similares
-
Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study
por: Zhang, Zhanchou, et al.
Publicado: (2014) -
Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
por: Lee, Jung Goo, et al.
Publicado: (2012) -
The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia
por: Guo, Xiaofeng, et al.
Publicado: (2013) -
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
por: Abdallah, Mahmoud S., et al.
Publicado: (2022) -
Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study
por: Bai, Luyuan, et al.
Publicado: (2023)